Advertisement
Singapore markets close in 43 minutes

  • Straits Times Index

    3,279.19
    -8.56 (-0.26%)
     

  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     

  • Hang Seng

    17,675.82
    +391.28 (+2.26%)
     

  • FTSE 100

    8,117.65
    +38.79 (+0.48%)
     

  • Bitcoin USD

    64,426.15
    +367.19 (+0.57%)
     

  • CMC Crypto 200

    1,387.63
    -8.90 (-0.64%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • Dow

    38,085.80
    -375.12 (-0.98%)
     

  • Nasdaq

    15,611.76
    -100.99 (-0.64%)
     

  • Gold

    2,358.70
    +16.20 (+0.69%)
     

  • Crude Oil

    84.02
    +0.45 (+0.54%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • FTSE Bursa Malaysia

    1,573.97
    +4.72 (+0.30%)
     

  • Jakarta Composite Index

    7,058.24
    -97.06 (-1.36%)
     

  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

Global Blood: 3Q Earnings Snapshot

Global Blood: 3Q Earnings Snapshot

Associated Press

SOUTH SAN FRANCISCO, Calif. (AP) _ Global Blood Therapeutics Inc. (GBT) on Tuesday reported a loss of $43.1 million in its third quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of 83 cents.

The results surpassed Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for a loss of 84 cents per share.

Global Blood shares have increased roughly 1 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $39.64, a drop of roughly 5 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GBT at https://www.zacks.com/ap/GBT